SK Chemicals erectile dysfunction drug receives marketing Approval in Korea

Published: 2007-07-30 07:00:00

Updated: 2007-07-30 07:00:00

SK Chemicals announced that it has recently received marketing approval from the Korean Food and Drug Administration for mirodenafil, a new phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction (ED).

Mirodenafil will be soon marketed in Korea under the brand name M-Vix in 100 mg t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK